Financials · SURG

SurgePays Inc. (SURG) financials

For the twelve months ended Jun 30, 2026, SurgePays Inc. reported $67.06M of revenue and -$32.11M of net income.

Revenue, TTM
$67.06M
Revenue growth, YoY
+83.9%
Net income, TTM
-$32.11M
Net margin
-47.9%
EPS, diluted, TTM
-$1.52
Cash
$1.95M
Total debt
$22.68M
P/S
0.15
Market cap
$10.1M
Annual revenue$56.96M
FY2016FY2025
Annual net income-$36.07M
FY2016FY2025
Annual free cash flow-$21.31M
FY2016FY2025

SURG revenue and earnings growth

SURG revenueQ2 2026$16.20M

Quarter YoY
+40.7%
QoQ
+1.4%
FY YoY
-6.4%
5Y CAGR
+0.9%
10Y CAGR
+35.0%

SURG revenue was $16.20M in fiscal Q2 2026 (ended Jun 30, 2026), up 40.7% from a year earlier and up 1.4% from the prior quarter. For the full fiscal 2025 it was $56.96M, down 6.4% from fiscal 2024. Compound annual growth was +0.9% over 5 years and +35.0% over 10 years. It rose in 7 of the last 10 fiscal years.

SURG net incomeQ2 2026$1.29M

SURG net income was $1.29M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$7.08M a year earlier. For the full fiscal 2025 it was -$36.07M, compared with -$45.73M in fiscal 2024.

SURG EPSQ2 2026$0.05

SURG diluted EPS was $0.05 in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$0.36 a year earlier. For the full fiscal 2025 it was -$1.80, compared with -$2.39 in fiscal 2024.

SURG free cash flowFY2025-$21.31M

SURG free cash flow was -$21.31M for fiscal 2025 (ended Dec 31, 2025), compared with -$21.83M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue$56.96M$60.88M$137.14M$121.54M$51.06M$54.41M$25.74M$15.24M$13.46M$3.30M
Cost of revenue$67.55M$75.21M$101.50M$108.07M$44.89M$51.94M$22.62M$8.57M$8.10M$2.33M
Gross profit-$10.59M-$14.32M$35.64M$13.47M$6.17M$2.47M$3.12M$6.67M$5.36M$968.3K
Selling, general and admin$20.07M$27.46M$16.78M$12.84M$12.16M$12.61M$10.66M$8.06M$5.15M$3.27M
Operating income-$34.14M-$43.46M$18.87M$633.8K-$5.99M-$10.15M-$7.77M-$1.54M$204.3K-$3.11M
Interest expense$2.00M$554.2K-$400.0K------
Pre-tax income-$36.07M-$43.07M$18.38M-$553.2K--$10.72M-$8.45M-$1.46M$2.77M-$4.60M
Income tax-$2.87M-$2.27M----$82.2K--
Net income-$36.07M-$45.73M$20.62M-$680.8K-$13.53M-$10.72M-$8.45M-$1.54M$2.77M-$4.60M
EPS, basic-$1.80-$2.39$1.45-$0.05-$3.09-$5.02-$4.50-$1.00$2.00-$5.00
EPS, diluted-$1.80-$2.39$1.38-$0.05-$3.09-$5.02-$4.50-$1.00$2.00-$5.00
Diluted shares20.1M19.1M14.9M12.4M4.4M2.1M1.9M1.6M1.5M895,926.36

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Cash and equivalents$1.73M$11.79M$14.62M$7.04M$6.28M$674.0K$346.0K$444.6K$1.27M$439.3K
Receivables$4.05M$3.00M$9.54M$9.23M$3.25M$180.5K$3.06M$206.7K$5.5K$126.4K
Inventory$339.6K$1.78M$9.05M$11.19M$4.36M$178.3K----
Current assets$6.98M$17.87M$33.37M$27.56M$13.89M$1.25M$3.57M$3.06M$2.99M$758.8K
Goodwill-$3.30M$1.67M$1.67M$866.8K$866.8K$866.8K$866.8K$866.8K$866.8K
Total assets$8.52M$23.98M$41.93M$34.00M$19.50M$7.33M$9.99M$4.08M$3.08M$2.36M
Current liabilities$18.20M$6.06M$12.71M$23.46M$10.00M$15.66M$7.05M$4.79M$2.81M$4.06M
Short-term debt$16.96M-----$736.2K$582.5K$435.0K$1.79M
Long-term debt$5.17M$0---$1.12M$2.21M$680.0K$52.2K$58.7K
Total debt$22.13M$0$460.5K$7.67M-$1.12M$2.94M$1.26M$487.2K$1.85M
Total liabilities$23.92M$8.71M$13.52M$28.89M$15.95M$18.05M$14.69M$6.07M$3.69M$4.17M
Shareholders' equity-$15.35M$15.26M$28.40M$5.12M$3.55M-$10.73M-$4.70M-$1.99M-$617.2K-$3.38M

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Operating cash flow-$21.29M-$21.31M$10.29M$793.3K-$15.29M-$4.33M-$6.53M-$1.02M$227.8K-$641.9K
Capital expenditures$18.6K$518.2K-$11.4K$51.4K$6.6K$227.6K$331.8K$147.0K$3.0K
Free cash flow-$21.31M-$21.83M-$781.9K-$15.34M-$4.33M-$6.76M-$1.35M$80.8K-$644.9K
Investing cash flow-$18.6K-$3.00M-$281.3K-$1.50M-$376.7K$8.4K-$32.2K-$278.0K-$147.0K-$503.0K
Financing cash flow$10.53M$22.48M-$2.42M$1.46M$21.27M$4.65M$6.47M$464.1K$607.1K$1.14M
Share repurchases-----$500.0K----
Stock-based compensation$1.70M$1.61M$613.8K$37.2K$3.6K$183.0K$329.6K$157.9K--
Depreciation and amortization$206.2K$942.5K$935.0K$933.4K$759.4K$1.17M$227.3K$149.6K$6.9K$433.1K

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue growth, YoY-6.4%-55.6%12.8%138.0%-6.2%111.3%68.9%13.3%308.3%16.4%
Gross margin-18.6%-23.5%26.0%11.1%12.1%4.5%12.1%43.8%39.9%29.4%
Operating margin-59.9%-71.4%13.8%0.5%-11.7%-18.6%-30.2%-10.1%1.5%-94.2%
Net margin-63.3%-75.1%15.0%-0.6%-26.5%-19.7%-32.8%-10.1%20.6%-139.5%
Free cash flow margin-37.4%-35.9%-0.6%-30.0%-8.0%-26.3%-8.8%0.6%-19.6%
Return on equity--299.6%72.6%-13.3%-381.0%-----
Return on assets-423.6%-190.7%49.2%-2.0%-69.4%-146.4%-84.6%-37.7%90.0%-195.2%
Current ratio0.382.952.631.171.390.080.510.641.060.19
Debt to equity-0.000.021.50------

Source: XBRL data SurgePays Inc. files with the SEC, latest filing dated Aug 19, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 1-for-50, first reported Nov 15, 2021.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

SURG peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
SURG$67.06M+83.9%-$32.11M-47.9%$10.1M
OMC$24.76B+54.1%$704.90M2.8%$24.24B
WPP£13.55B-8.1%-£215.00M-1.6%$6.04B
STGW$3.11B+7.7%$9.69M0.3%$2.80B
IBTA$357.74M+1.6%-$16.06M-4.5%$1.41B
CRTO$1.81B-7.5%$77.95M4.3%$843.5M
GRPN$500.03M+0.8%-$8.36M-1.7%$508.7M
MNTN$323.56M+18.6%$57.63M17.8%$366.5M
ANGI$968.94M-8.4%-$231.08M-23.8%$270.3M

SURG FAQ

8 questions
  • What is SURG revenue?
    SurgePays Inc. (SURG) reported $67.06M of revenue for the twelve months ended Jun 30, 2026. That is up 83.9% from the year before. Revenue for fiscal 2025 was $56.96M.
  • Is SURG profitable?
    No. SurgePays Inc. reported a net loss of $32.11M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does SURG have?
    SurgePays Inc. reported $1.95M in cash and cash equivalents and $22.68M of debt on its most recent balance sheet in SEC filings.
  • How fast is SURG revenue growing?
    SurgePays Inc.'s revenue changed -6.4% in fiscal 2025, to $56.96M. Its compound annual growth rate was +0.9% over 5 years and +35.0% over 10 years.
  • What is SURG gross margin?
    SurgePays Inc.'s gross profit was -$13.11M on $67.06M of revenue for the twelve months ended Jun 30, 2026, a gross margin of -19.6%.
  • What is SURG earnings per share?
    Diluted earnings per share were -$1.52 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did SURG last report financial results?
    The latest statements here come from SurgePays Inc.'s 10-Q filed on Aug 19, 2026, covering the period ended Jun 30, 2026.
  • Where does this SURG financial data come from?
    Quantisnow builds these statements from the structured XBRL data SurgePays Inc. files with the SEC. It is provided for information only and is not investment advice.